Challenges in Conducting Studies in Chronic Graft-versus-Host Disease
The lack of standardized criteria for measuring therapeutic response has been a major obstacle to the development of therapeutic trials in chronic graft-versus-host disease (cGvHD). Nevertheless, recent advances have been made in understanding of the biology and pathophysiology of cGvHD, as well as...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Atlantis Press
2019-03-01
|
Series: | Clinical Hematology International |
Subjects: | |
Online Access: | https://www.atlantis-press.com/article/125905876/view |
id |
doaj-9af24f8668c546d4b230850627ccac13 |
---|---|
record_format |
Article |
spelling |
doaj-9af24f8668c546d4b230850627ccac132020-11-25T00:58:57ZengAtlantis PressClinical Hematology International2590-00482019-03-011110.2991/chi.d.190314.001Challenges in Conducting Studies in Chronic Graft-versus-Host DiseaseIskra PusicSteven Z. PavleticThe lack of standardized criteria for measuring therapeutic response has been a major obstacle to the development of therapeutic trials in chronic graft-versus-host disease (cGvHD). Nevertheless, recent advances have been made in understanding of the biology and pathophysiology of cGvHD, as well as establishing more precise criteria for the diagnosis and classification of disease manifestations. The momentum has shifted, and currently there is a long list of new potential treatment targets being identified for cGvHD. Consequently, new drugs are being implemented for its prophylaxis and treatment. It is crucial to continue that trend and develop better systems to test new drugs in clinical practice that would eventually translate toward seeking regulatory review and approval. We provide a historical perspective and current challenges in conducting cGvHD clinical trials.https://www.atlantis-press.com/article/125905876/viewGvHDGRFSFFSResponse criteriaComposite endpoints |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Iskra Pusic Steven Z. Pavletic |
spellingShingle |
Iskra Pusic Steven Z. Pavletic Challenges in Conducting Studies in Chronic Graft-versus-Host Disease Clinical Hematology International GvHD GRFS FFS Response criteria Composite endpoints |
author_facet |
Iskra Pusic Steven Z. Pavletic |
author_sort |
Iskra Pusic |
title |
Challenges in Conducting Studies in Chronic Graft-versus-Host Disease |
title_short |
Challenges in Conducting Studies in Chronic Graft-versus-Host Disease |
title_full |
Challenges in Conducting Studies in Chronic Graft-versus-Host Disease |
title_fullStr |
Challenges in Conducting Studies in Chronic Graft-versus-Host Disease |
title_full_unstemmed |
Challenges in Conducting Studies in Chronic Graft-versus-Host Disease |
title_sort |
challenges in conducting studies in chronic graft-versus-host disease |
publisher |
Atlantis Press |
series |
Clinical Hematology International |
issn |
2590-0048 |
publishDate |
2019-03-01 |
description |
The lack of standardized criteria for measuring therapeutic response has been a major obstacle to the development of therapeutic trials in chronic graft-versus-host disease (cGvHD). Nevertheless, recent advances have been made in understanding of the biology and pathophysiology of cGvHD, as well as establishing more precise criteria for the diagnosis and classification of disease manifestations. The momentum has shifted, and currently there is a long list of new potential treatment targets being identified for cGvHD. Consequently, new drugs are being implemented for its prophylaxis and treatment. It is crucial to continue that trend and develop better systems to test new drugs in clinical practice that would eventually translate toward seeking regulatory review and approval. We provide a historical perspective and current challenges in conducting cGvHD clinical trials. |
topic |
GvHD GRFS FFS Response criteria Composite endpoints |
url |
https://www.atlantis-press.com/article/125905876/view |
work_keys_str_mv |
AT iskrapusic challengesinconductingstudiesinchronicgraftversushostdisease AT stevenzpavletic challengesinconductingstudiesinchronicgraftversushostdisease |
_version_ |
1725219638551248896 |